Abstract

Introduction. Arboviral infections are a rising public health concern not only for some individual countries, but also for the entire world due to the repeated outbreaks over the past decade.The aim was to conduct a seroprevalence study of Dengue (DENV), Zika (ZIKV), Yellow fever (YFV) and Chikungunya (CHIKV) viruses using a limited number of samples in Nicaragua.Materials and methods. Total 200 serum samples collected previously in Nicaragua were analyzed simultaneously. Commercially available diagnostic kits, as well as in-house methods were used. The avidity of antibodies (IgG) in positive serum samples was assessed after the treatment with 8M urea.Results. 85 serum samples (42.5%) contained IgG antibodies to one or several viruses simultaneously. IgG antibodies only to one virus were detected in 46 serum samples (23%) with the avidity index (AI) ≥ 30%. Among 39 samples (19.5%) that contained IgG antibodies to several viruses, only in 19 samples (9.5%) IgG antibodies with high AI (≥ 30%) to several viruses were detected. In 16 serum samples (8.0%), IgG antibodies to DENV with a high AI and antibodies to ZIKV and/or YFV with a low AI 30% were detected.Discussion. The results obtained in ELISA testing were corrected, since only IgG antibodies with a high AI confirm the past infection. The analysis of the specific IgG antibody avidity helped not only to confirm the cases of combined or sequential infection in the past, but also to discriminate the cross-reactive IgG antibodies induced by closely related DENV, ZIKV and YFV. The presence of cross-reactive IgG antibodies, on the one hand, make it difficult to determine the real seroprevalence of flavivirus infections, and, on the other hand, may increase the risk of antibody-dependent enhancement (ADE) of the disease, which is well-known for the secondary Dengue fever and for the consecutive infection with DENV and ZIKV.Conclusion. The analysis of virus-specific antibody avidity made it possible not only to distinguish recent from the past infection, but also to discriminate the cross-reactive antibodies with the low avidity.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call